期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 209, 期 8, 页码 1469-1479出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20120423
关键词
-
资金
- Rockefeller University
- Research Council's Basic Technology Initiative 'Glycoarrays' [GRS/79268]
- EPSRC [EP/G037604/1]
- National Cancer Institute Alliance of Glycobiologists [U01CA128416]
- National Institutes of Health [NIH 1 PO1 AI081677]
- German Research Foundation (DFG) [KL 2389/1-1]
- German National Academic Foundation
- German Federal Ministry of Education and Research [BMBF 01 KI 0771]
- Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium [1032144]
- Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish
- EPSRC [EP/G037604/1] Funding Source: UKRI
Two to three years after infection, a fraction of HIV-1-infected individuals develop serologic activity that neutralizes most viral isolates. Broadly neutralizing antibodies that recognize the HIV-1 envelope protein have been isolated from these patients by single-cell sorting and by neutralization screens. Here, we report a new method for anti-HIV-1 antibody isolation based on capturing single B cells that recognize the HIV-1 envelope protein expressed on the surface of transfected cells. Although far less efficient than soluble protein baits, the cell-based capture method identified antibodies that bind to a new broadly neutralizing epitope in the vicinity of the V3 loop and the CD4-induced site (CD4i). The new epitope is expressed on the cell surface form of the HIV-1 spike, but not on soluble forms of the same envelope protein. Moreover, the new antibodies complement the neutralization spectrum of potent broadly neutralizing anti-CD4 binding site (CD4bs) antibodies obtained from the same individual. Thus, combinations of potent broadly neutralizing antibodies with complementary activity can account for the breadth and potency of naturally arising anti-HIV-1 serologic activity. Therefore, vaccines aimed at eliciting anti-HIV-1 serologic breadth and potency should not be limited to single epitopes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据